chr4-56467693-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP4_StrongBP6_Very_StrongBS2

The NM_006947.4(SRP72):​c.58C>T​(p.Arg20Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00408 in 1,554,546 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R20P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0029 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0042 ( 19 hom. )

Consequence

SRP72
NM_006947.4 missense

Scores

7
5
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 4.75

Publications

9 publications found
Variant links:
Genes affected
SRP72 (HGNC:11303): (signal recognition particle 72) This gene encodes the 72 kDa subunit of the signal recognition particle (SRP), a ribonucleoprotein complex that mediates the targeting of secretory proteins to the endoplasmic reticulum (ER). The SRP complex consists of a 7S RNA and 6 protein subunits: SRP9, SRP14, SRP19, SRP54, SRP68, and SRP72, that are bound to the 7S RNA as monomers or heterodimers. SRP has at least 3 distinct functions that can be associated with the protein subunits: signal recognition, translational arrest, and ER membrane targeting by interaction with the docking protein. Mutations in this gene are associated with familial bone marrow failure. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
SRP72 Gene-Disease associations (from GenCC):
  • autosomal dominant aplasia and myelodysplasia
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • acute myeloid leukemia
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, Cadd, Dann, Eigen, FATHMM_MKL, PROVEAN [when BayesDel_addAF, max_spliceai, M_CAP, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.01167652).
BP6
Variant 4-56467693-C-T is Benign according to our data. Variant chr4-56467693-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 349117.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 440 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRP72NM_006947.4 linkc.58C>T p.Arg20Trp missense_variant Exon 1 of 19 ENST00000642900.1 NP_008878.3 O76094-1V9HWK0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRP72ENST00000642900.1 linkc.58C>T p.Arg20Trp missense_variant Exon 1 of 19 NM_006947.4 ENSP00000495128.1 O76094-1

Frequencies

GnomAD3 genomes
AF:
0.00291
AC:
440
AN:
150982
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000950
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00276
Gnomad ASJ
AF:
0.00145
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00189
Gnomad FIN
AF:
0.000777
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00485
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.00260
AC:
534
AN:
205648
AF XY:
0.00277
show subpopulations
Gnomad AFR exome
AF:
0.000926
Gnomad AMR exome
AF:
0.00151
Gnomad ASJ exome
AF:
0.000916
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000949
Gnomad NFE exome
AF:
0.00428
Gnomad OTH exome
AF:
0.00284
GnomAD4 exome
AF:
0.00421
AC:
5909
AN:
1403452
Hom.:
19
Cov.:
33
AF XY:
0.00412
AC XY:
2874
AN XY:
697408
show subpopulations
African (AFR)
AF:
0.000911
AC:
27
AN:
29638
American (AMR)
AF:
0.00205
AC:
74
AN:
36146
Ashkenazi Jewish (ASJ)
AF:
0.000652
AC:
16
AN:
24534
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33452
South Asian (SAS)
AF:
0.00190
AC:
153
AN:
80468
European-Finnish (FIN)
AF:
0.00139
AC:
72
AN:
51672
Middle Eastern (MID)
AF:
0.00107
AC:
6
AN:
5622
European-Non Finnish (NFE)
AF:
0.00494
AC:
5358
AN:
1084238
Other (OTH)
AF:
0.00352
AC:
203
AN:
57682
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
326
653
979
1306
1632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00291
AC:
440
AN:
151094
Hom.:
1
Cov.:
31
AF XY:
0.00272
AC XY:
201
AN XY:
73792
show subpopulations
African (AFR)
AF:
0.000947
AC:
39
AN:
41174
American (AMR)
AF:
0.00276
AC:
42
AN:
15222
Ashkenazi Jewish (ASJ)
AF:
0.00145
AC:
5
AN:
3454
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5086
South Asian (SAS)
AF:
0.00189
AC:
9
AN:
4762
European-Finnish (FIN)
AF:
0.000777
AC:
8
AN:
10290
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00485
AC:
329
AN:
67798
Other (OTH)
AF:
0.00332
AC:
7
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00378
Hom.:
8
Bravo
AF:
0.00305
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00649
AC:
25
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00512
AC:
44
ExAC
AF:
0.00269
AC:
327
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 23, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SRP72: BS1, BS2 -

Autosomal dominant aplasia and myelodysplasia Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 06, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Apr 24, 2019
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SRP72-related disorder Benign:1
Mar 03, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Benign
-0.060
T
BayesDel_noAF
Pathogenic
0.14
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.27
T;.;T;T
Eigen
Pathogenic
0.77
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Benign
0.74
D
LIST_S2
Uncertain
0.91
D;D;.;D
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.012
T;T;T;T
MetaSVM
Benign
-0.73
T
MutationAssessor
Uncertain
2.6
M;M;M;.
PhyloP100
4.7
PrimateAI
Uncertain
0.70
T
PROVEAN
Pathogenic
-5.3
D;D;.;.
REVEL
Uncertain
0.30
Sift
Uncertain
0.0010
D;D;.;.
Sift4G
Pathogenic
0.0010
D;D;.;D
Polyphen
1.0
D;.;D;.
Vest4
0.62
MVP
0.68
MPC
0.54
ClinPred
0.035
T
GERP RS
5.5
PromoterAI
-0.028
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.66
gMVP
0.56
Mutation Taster
=42/58
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111673705; hg19: chr4-57333859; COSMIC: COSV108167095; COSMIC: COSV108167095; API